Parkinson’s Disease: From Pathogenesis to Pharmacogenomics

Parkinson’s Disease: From Pathogenesis to Pharmacogenomics

Parkinson’s disease (PD) is the second most important age-related neurodegenerative disorder in developed societies, after Alzheimer’s disease, with a prevalence ranging from 41 per 100,000 in the fourth decade of life to over 1900 per 100,000 in people over 80 years of age. As a movement disorder,...

Full description

Bibliographic Details
Main Author: Ramón Cacabelos
Format: Article
Language:English
Published: MDPI AG 2017-03-01
Series:International Journal of Molecular Sciences
Subjects:
adrenaline
antiparkinsonian drugs
Atremorine
dopamine
genomics
growth hormone
noradrenaline
Parkinson’s disease
pharmacogenetics
prolactin
Online Access:http://www.mdpi.com/1422-0067/18/3/551

Internet

http://www.mdpi.com/1422-0067/18/3/551

Similar Items